Pulmonary Atresia: Intact Septum, VSD and the Newborn Lung-Blood Route

Direct answer. Pulmonary atresia is a congenital obstruction of the usual route from the right ventricle into the pulmonary artery. It can cause critical low oxygen in a newborn. The intact-septum form and the form with a ventricular septal defect, or VSD, require different anatomical assessments; treatment may preserve another lung-blood route, open or reconstruct a suitable outlet, or establish a staged circulation. Confidence is high in these distinctions. No universal catheter or surgical pathway is established here. CDC pulmonary atresia and subtype context, January2026; Evelina London original congenital condition and selected-care education.

Evidence summary

Confidence is high in the condition distinctions and need for appropriate assessment. The treatment section attributes clinical guidance; it does not certify the funding of every underlying intervention trial. Independent comparative outcome certainty and a supplement replacement regimen were not established by this focused review. A public institution or independent review cannot make a sponsored original trial financially independent.

What it is

Normally, the right ventricle sends blood through the pulmonary outlet toward the lungs to collect oxygen. In pulmonary atresia, the normal route is blocked. Pulmonary valve stenosis describes narrowing, while atresia describes an absent usable passage. The distinction matters because a general explanation of balloon treatment for a narrowed valve does not establish that every atretic outlet can be opened safely. NHLBI congenital anatomy and condition taxonomy, March2022; CDC pulmonary atresia and subtype context, January2026.

The diagnosis needs more detail than the condition name. The right ventricle and pulmonary arteries may be underdeveloped, and other valves or connections can be abnormal. Imaging should describe how blood currently reaches the lungs as well as the blocked route. A chamber-size label alone cannot select an intervention. GOSH pulmonary atresia anatomy.

How it works

With an intact ventricular septum, there is no VSD between the ventricles and the right-sided pumping structures can be small. GOSH includes this pattern among conditions assessed by its single-ventricle service. That service context does not mean that every child with the label must undergo the same operation: functional suitability needs its own assessment. GOSH single-ventricle service anatomical condition distinctions.

In the VSD-associated pattern, ventricular and lung-vessel relationships differ. Alternative vessels can contribute to pulmonary blood flow, so the team needs to define the actual connections rather than infer the circulation from a valve drawing. The questions are which vessels supply which areas and what route is available now. Evelina London original congenital condition and selected-care education.

A ductus arteriosus can supply essential blood toward the lungs early in life. Its changing patency can therefore affect the baby’s condition. Closing a PDA in another circulation and supporting a necessary duct in this circulation serve different purposes. Families should never transfer a duct-closing medicine or a closure recommendation between those situations. Evelina London original congenital condition and selected-care education.

Diagnosis may begin before birth or follow signs after delivery. Echocardiography defines anatomy; selected additional investigations clarify unresolved questions. A murmur can be absent, and oxygen screening cannot detect every critical defect. A reassuring earlier screen or quiet examination should not override new significant illness. CDC pulmonary atresia and subtype context, January2026; CDC professional critical-heart screening limitations, December2025.

The evidence-based treatments

Immediate care focuses on oxygen delivery and the actual circulation. Specialist support may keep an essential ductal route open while intervention is planned. This is a monitored clinical treatment, not an instruction for families to use a retail drug or adjust an existing prescription themselves. CDC pulmonary atresia and subtype context, January2026.

Selected catheter intervention can open a suitable pulmonary outlet or support an alternative route. Outlet opening and ductal stenting are distinct procedures with different targets. The provider’s description is clinical context; it does not establish that either procedure fits every intact-septum case or that a small ventricle is guaranteed to grow sufficiently afterward. Evelina London original congenital condition and selected-care education.

Other anatomy may require surgical reconstruction or a staged route using the available pumping capacity. General congenital treatment education includes surgery and selected catheter procedures, with the approach chosen for the defect. A reader cannot determine two-ventricle suitability, procedural safety or the need for a later stage from the diagnosis alone. NHLBI congenital procedure background, March2022.

Where a staged circulation leads to a Fontan pathway, later care concerns more than the initial pulmonary outlet. Ventricular function, rhythm and other organs can require coordinated review. This is a conditional description of a possible circulation, not a claim that Fontan is the universal treatment for pulmonary atresia. Leeds Fontan circulation and organ follow-up, January2026.

Prenatal discussions should explain the expected early needs, remaining uncertainty and delivery plan. A fetal diagnosis does not make every subsequent detail predictable. The actual December2025 counselling leaflet supports individualized discussion and wider fetal assessment; its population recurrence estimates are not reproduced as a personal prediction. Evelina London prenatal congenital diagnosis and counselling, December2025.

Supplement and lifestyle evidence

Feeding and growth plans should reflect the present oxygenation and workload. Recovery, development and activity advice can change after intervention and should remain specific to the current stage. Family psychological and practical support can help alongside cardiac care. General cardiovascular habits support wellbeing but cannot construct a missing outlet or prove that further procedures will be unnecessary. NHLBI lifelong congenital follow-up, March2022.

No supplement is established here as a treatment for pulmonary atresia. “Heart support,” improved vessel relaxation, a changed blood marker and fewer clinical events are different claims. The cited source set does not provide a fully financially screened trial basis for replacing diagnosis or prescribed care. Correcting a clinician-confirmed deficiency is a separate indication; a retail blend is not a diagnostic test or an emergency treatment.

What works and what does not

Useful care identifies how blood reaches the lungs today and why the proposed intervention changes that route. It distinguishes a technically successful procedure from adequate oxygenation, suitable ventricular function and longer-term outcome. A diagram should support the explanation, rather than suggest that every small right ventricle or blocked valve has the same treatment. A staged route should name the present stage and remaining decisions.

Ask which outcome is being pursued: symptoms, physiological findings, recurrence, hospital admission or survival. A plan should also say how adverse effects and deterioration will be recognized. Personal stories and before-and-after readings cannot separate treatment effects from the natural course, other medicines or selection of patients. Manufacturer or materially conflicted outcome claims do not determine this article’s independent verdict.

Risks and side effects

A newborn or child with severe breathing difficulty, blue/grey colour, limpness, collapse or reduced responsiveness needs emergency help. Feeding deterioration with a substantial breathing or activity change needs prompt assessment. A passed newborn oxygen screen must not delay help. Families with a known diagnosis need a written contact plan appropriate to the current circulation. NHS congenital heart disease national guidance, December2025; CDC professional critical-heart screening limitations, December2025.

Low oxygen and an inadequate pulmonary blood route can be serious. Catheter procedures, surgery and medicines also carry risks, including bleeding, injury, infection and residual dysfunction. The early anatomical result does not establish that every future procedure will be avoided. This article does not provide a personal survival estimate or financially cleared comparative ranking of reconstruction techniques. NHLBI congenital procedure background, March2022.

Important interactions

The congenital team should review prescriptions and supplements together, including any medicine intended to support a duct, rhythm or fluid balance. These treatments have different goals and should not be exchanged. Do not add a product promoted to open blood vessels or copy a preterm-PDA drug regimen. Later reproductive decisions and medication review require the actual congenital circulation and current function. NHLBI congenital pregnancy and medicine review, March2022.

Bring prescription medicines, non-prescription products, recreational drugs and supplements to the same medication review. Product names alone may hide several active ingredients. The prescriber or pharmacist should check the exact combination and kidney function, rather than treating “natural” as a safety category. Never add a second person’s rescue medicine or stop an important prescribed medicine because an internet list mentions a possible interaction.

Who needs assessment

Ask for the septal anatomy, right-ventricular capacity, pulmonary vessels and present alternative route to be explained together. Current imaging and clinical findings should answer a defined question. A wearable oxygen result cannot establish procedural suitability or determine which connection should be changed. Previous intervention records matter because the circulation may differ substantially from the original anatomy. NHLBI congenital investigation education, March2022.

Pregnancy and contraception planning should use the actual anatomy, current function and medicine list. A childhood repair label alone cannot establish present safety. Clinical genetic counselling may be appropriate when the question is defined; an inconclusive or negative result does not settle all congenital risk. NHLBI congenital pregnancy and medicine review, March2022.

Clinician-led use and follow-up

Keep the original anatomy, completed catheter or surgical procedures and present circulation in the care record. Ask which clinical and imaging findings will be followed, what deterioration needs rapid contact and who coordinates the next decision. Transition to adult congenital services should retain these details. A childhood description such as “valve fixed” cannot substitute for the operative record and current physiological assessment. AHA original2025 congenital patient messages.

This guide gives no personal drug, device or supplement dose. The appropriate plan depends on the established diagnosis, current stability, other illnesses and local services. Ask for a written explanation of the treatment purpose, warning signs, review schedule and contact route for side effects. Clinical monitoring and informed consent should accompany any change; study exposures are not prescriptions.

Animal and in-vitro evidence

Animal and cellular studies of heart development can investigate mechanisms and candidate genes. They cannot establish a safe human supplement regimen, prove that a structural defect will close, or select an operation for a child or adult. Models may differ substantially from a person’s congenital anatomy and circulation. No animal or in-vitro result contributes to the independent clinical verdict in this guide.

Funding and source roles

Financial interests include specialist imaging, genomic testing, pediatric and adult congenital services, medicines, occluders, conduits and valve implants. Institutional public funding does not clear individual research sponsors. The actual funding routes and unresolved author/trial chain are shown source by source. Manufacturer or materially conflicted clinical outcomes do not determine this article’s independent verdict.

The condition has no corporate owner. Medicines, diagnostics, devices, procedures and marketed supplements create different revenue incentives. This describes financial interests rather than misconduct. Funding tier evaluates proximity to the subject; A–D credibility assesses transparency, accuracy incentives and remaining uncertainty. An unresolved link stays unresolved, and a provisional public-information label does not clear the trials behind it.

Frequently asked questions

Is pulmonary atresia another name for pulmonary stenosis? No. The usual outlet is blocked rather than merely narrowed. NHLBI congenital anatomy and condition taxonomy, March2022.

Does every case have a hole between the ventricles? No. Intact-septum and VSD-associated forms differ. CDC pulmonary atresia and subtype context, January2026.

Should every PDA be closed? No. An essential duct can supply lung blood in this circulation. Evelina London original congenital condition and selected-care education.

Does the condition name decide the operation? No. Full anatomical and physiological assessment is required.

Sources and funding notes

• NHLBI congenital heart defects overview, March2022 — Congenital definition and varied severity.
• NHLBI congenital contributors and unresolved causes, March2022 — Contributors and frequent uncertainty; no attribution of individual parental blame.
• NHLBI congenital symptom education, March2022 — Dated symptom education, not a diagnostic screen.
• NHLBI congenital investigation education, March2022 — Anatomy, rhythm and selected investigation context.
• NHLBI congenital procedure background, March2022 — Dated medicine/procedure background; no universal closure or transplant rule.
• NHLBI lifelong congenital follow-up, March2022 — Age-appropriate long-term care and activity.
• NHLBI congenital pregnancy and medicine review, March2022 — Individual reproductive and medication assessment.
• NHS congenital heart disease national guidance, December2025 — December2025 current national condition and emergency education.
• AHA original2025 congenital patient messages — December2025 transition and specialist-care messages, C-provisional clinical context.
• NHLBI congenital anatomy and condition taxonomy, March2022 — Critical congenital taxonomy and separate pulmonary stenosis.
• CDC pulmonary atresia and subtype context, January2026 — January2026 blocked outlet and intact-septum/VSD distinctions; imprecise catheter wording not imported.
• CDC professional critical-heart screening limitations, December2025 — December2025 oxygen-screen limitations.
• GOSH pulmonary atresia anatomy — Right-ventricular and pulmonary-vessel anatomical variation.
• GOSH single-ventricle service anatomical condition distinctions — Intact-septum anatomy and selected single-ventricle service context.
• Evelina London original congenital condition and selected-care education — Duct, alternative vessel and selected outlet intervention context.
• Evelina London prenatal congenital diagnosis and counselling, December2025 — December2025 counselling, delivery and wider fetal assessment.
• Leeds Fontan circulation and organ follow-up, January2026 — Later staged-circulation and organ review context, not an automatic pathway.
• NHLBI budget — Financial provenance only.
• NHLBI Gift Fund — Financial provenance only.
• NHS national website funding policy — Financial provenance only.
• GOSH audited annual accounts 2025–26 — Financial provenance only.
• Leeds Teaching Hospitals audited2025–26 accounts — Financial provenance only.
• Leeds2026 annual report publication and institution location — Financial provenance only.
• AHA2024–25 annual report and named corporate support — Financial provenance only.
• AHA National Center Dallas contact — Financial provenance only.
• CDC original FY2026 operating plan — Financial provenance only.
• CDC dated2016 gift authority,2022 editorial review — Financial provenance only.
• CDC actual Atlanta contact and public-site provenance — Financial provenance only.
• Guy’s and St Thomas’ audited2025–26 accounts — Financial provenance only.

Original clinical pages and their relevant financial disclosures were opened. Actual December2025 AHA adult-congenital summaries and patient messages were read. The full2025 ACC/AHA/HRS/ISACHD/SCAI guideline, author-declaration chain and slide download were blocked and were not read. No complete guideline assessment or numeric intervention criterion is inferred from the summaries. AHA2024–25 institutional financial disclosures and Dallas contact were checked; joint-society finances and direct page allocation remain unresolved. Institutional corporate funding is not assumed to fund this particular document. These summaries are attributed C-provisional clinical context, excluded from the independent efficacy verdict. Leeds Teaching Hospitals2025–26 original audited accounts were read separately from national NHS policy. Clinical leaflet review dates are source-specific and do not establish that every cited study was updated. Local procedure rates, fixed antithrombotic doses and recovery promises are not imported as independent evidence or personal instructions. Public clinical sources concentrate on US and English services; referral and treatment availability vary by jurisdiction. Guidance, classification, emergency education and independent efficacy are distinct source roles. A full systematic review, complete society donor audit and author-by-author clearance of original treatment trials were not completed.

Last reviewed: October 4, 2026. Educational information, not a diagnosis or personal treatment plan. Use your local emergency service for an emergency.